296 related articles for article (PubMed ID: 20714802)
1. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
[TBL] [Abstract][Full Text] [Related]
2. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
[TBL] [Abstract][Full Text] [Related]
4. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.
Dawson DW; Pearce SF; Zhong R; Silverstein RL; Frazier WA; Bouck NP
J Cell Biol; 1997 Aug; 138(3):707-17. PubMed ID: 9245797
[TBL] [Abstract][Full Text] [Related]
5. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
6. TSP2 acts as a suppresser of cell invasion, migration and angiogenesis in medulloblastoma by inhibiting the Notch signaling pathway.
Pan W; Song XY; Hu QB; Zhang M; Xu XH
Brain Res; 2019 Sep; 1718():223-230. PubMed ID: 31063715
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.
Ren B; Hale J; Srikanthan S; Silverstein RL
Blood; 2011 Jun; 117(22):6036-45. PubMed ID: 21441463
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.
Chu LY; Ramakrishnan DP; Silverstein RL
Blood; 2013 Sep; 122(10):1822-32. PubMed ID: 23896411
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
11. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.
Chen ZS; Pohl J; Lawley TJ; Swerlick RA
J Invest Dermatol; 1996 Feb; 106(2):215-20. PubMed ID: 8601718
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism.
Armstrong LC; Björkblom B; Hankenson KD; Siadak AW; Stiles CE; Bornstein P
Mol Biol Cell; 2002 Jun; 13(6):1893-905. PubMed ID: 12058057
[TBL] [Abstract][Full Text] [Related]
13. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondins and tumor angiogenesis.
de Fraipont F; Nicholson AC; Feige JJ; Van Meir EG
Trends Mol Med; 2001 Sep; 7(9):401-7. PubMed ID: 11530335
[TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.
Jiménez B; Volpert OV; Reiher F; Chang L; Muñoz A; Karin M; Bouck N
Oncogene; 2001 Jun; 20(26):3443-8. PubMed ID: 11423995
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin 1 Triggers Osteosarcoma Cell Metastasis and Tumor Angiogenesis.
Jian YK; Zhu HY; Wu XL; Li B
Oncol Res; 2019 Feb; 27(2):211-218. PubMed ID: 29540257
[TBL] [Abstract][Full Text] [Related]
17. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
[TBL] [Abstract][Full Text] [Related]
18. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
[TBL] [Abstract][Full Text] [Related]
20. Human thrombospondin 2 inhibits proliferation of microvascular endothelial cells.
Tomii Y; Kamochi J; Yamazaki H; Sawa N; Tokunaga T; Ohnishi Y; Kijima H; Ueyama Y; Tamaoki N; Nakamura M
Int J Oncol; 2002 Feb; 20(2):339-42. PubMed ID: 11788898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
